Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Invested Capital (2016 - 2025)

iBio (IBIO) has disclosed Invested Capital for 15 consecutive years, with $56.6 million as the latest value for Q4 2025.

  • Quarterly Invested Capital rose 302.56% to $56.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $56.6 million through Dec 2025, up 302.56% year-over-year, with the annual reading at $14.9 million for FY2025, 30.5% down from the prior year.
  • Invested Capital for Q4 2025 was $56.6 million at iBio, up from $56.1 million in the prior quarter.
  • The five-year high for Invested Capital was $108.6 million in Q2 2021, with the low at $9.2 million in Q4 2023.
  • Average Invested Capital over 5 years is $44.4 million, with a median of $23.2 million recorded in 2024.
  • The sharpest move saw Invested Capital surged 2549.23% in 2021, then plummeted 79.22% in 2022.
  • Over 5 years, Invested Capital stood at $90.6 million in 2021, then tumbled by 79.22% to $18.8 million in 2022, then tumbled by 51.14% to $9.2 million in 2023, then soared by 52.77% to $14.0 million in 2024, then surged by 302.56% to $56.6 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at $56.6 million, $56.1 million, and $14.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.